The fine line between therapeutic benefit and toxicity
In this issue of the Journal, Ahmed and colleagues1 focus our attention on the very real problem of gentamicin-induced ototoxicity, and especially on the frequently unrecognised problem of severe vestibulotoxicity. Their retrospective analysis of gentamicin-treated patients presenting to a balance disorders clinic found delayed clinical detection of vestibulotoxicity and an apparent lack of a relationship between toxicity and dose. While hearing loss can be a feature of gentamicin ototoxicity, it is uncommon and usually clinically insignificant. The most concerning aspect of the analysis is the authors’ inability to demonstrate any relationship between vestibulotoxicity and gentamicin doses, dosing schedules or exposure (ie, peaks and/or troughs).1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Ahmed RM, Hannigan IP, MacDougall HG, et al. Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust 2012; 196: 701-704. <MJA full text>
- 2. Drusano GL, Ambrose PG, Bhavnani SM, et al. Back to the future: using aminoglycosides again and how to use them optimally. Clin Infect Dis 2007; 45: 753-760.
- 3. Beaubien AR, Desjardins S, Ormsby E, et al. Incidence of amikacin ototoxicity: a sigmoid function of total drug exposure independent of plasma levels. Am J Otolaryngol 1989; 10: 234-243.
- 4. Beaubien AR, Ormsby E, Bayne A, et al. Evidence that amikacin ototoxicity is related to the total perilymph area under the concentration-time curve regardless of concentration. Antimicrob Agents Chemother 1991; 35: 1070-1074.
- 5. Munckhof WJ, Grayson ML, Turnidge JD. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996; 37: 645–663.
- 6. Black FO, Peterka RJ, Elardo SE. Vestibular reflex changes following aminoglycoside induced ototoxicity. Laryngoscope 1987; 97: 582-586.
- 7. Craig WA. Gentamicin. In: Grayson ML et al, editors. Kucers’ the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs. 6th ed. Chapter 53. London: Hodder Arnold, 2010.
- 8. Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Ltd, 2010.
- 9. Moulds RF, Jeyasingham MF. Gentamicin: a great way to start [editorial]. Aust Prescr 2010; 33: 134-135.
No relevant disclosures.